Skip to content
10-Q

Quarterly Report

OXFORD IMMUNOTEC GLOBAL PLC

0001437749-20-022320

← back to feed
Filed
Nov 3, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 26, 2020 25.96M sh
Shares Diluted Q3 2020 · Sep 30, 2020 25.9M sh
Shares Diluted Q3 2020 · Sep 30, 2020 25.98M sh
Shares Diluted Q3 2020 · Sep 30, 2019 26.94M sh
Shares Diluted Q3 2020 · Sep 30, 2019 26.9M sh
Stock Repurchased Q3 2020 · Sep 30, 2020 $7.73M
Stock Repurchased Q3 2020 · Sep 30, 2019 $3.33M
Capex Q3 2020 · Sep 30, 2020 $3.97M
Capex Q3 2020 · Sep 30, 2019 $729K
Cash And Equivalents Q3 2020 · Sep 30, 2020 $160.62M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $181.27M
Stockholders Equity Q3 2020 · Sep 30, 2020 $191.26M
Stockholders Equity Q3 2020 · Jun 30, 2020 $188.89M
Stockholders Equity Q3 2020 · Mar 31, 2020 $198.01M
Stockholders Equity Q3 2020 · Dec 31, 2019 $213.69M
Stockholders Equity Q3 2020 · Sep 30, 2019 $214.97M
Stockholders Equity Q3 2020 · Jun 30, 2019 $217.78M
Stockholders Equity Q3 2020 · Mar 31, 2019 $216.18M
Stockholders Equity Q3 2020 · Dec 31, 2018 $214.01M
Current Liabilities Q3 2020 · Sep 30, 2020 $11.8M
Current Liabilities Q3 2020 · Dec 31, 2019 $13.82M
Total Liabilities Q3 2020 · Sep 30, 2020 $19.24M
Total Liabilities Q3 2020 · Dec 31, 2019 $21.56M
Current Assets Q3 2020 · Sep 30, 2020 $188.37M
Current Assets Q3 2020 · Dec 31, 2019 $215.88M
Total Assets Q3 2020 · Sep 30, 2020 $210.5M
Total Assets Q3 2020 · Dec 31, 2019 $235.25M
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.01
Eps Diluted Q3 2020 · Sep 30, 2020 −$0.61
Eps Diluted Q3 2020 · Sep 30, 2019 $0.03
Eps Diluted Q3 2020 · Sep 30, 2019 −$0.01
Eps Basic Q3 2020 · Sep 30, 2020 −$0.01
Eps Basic Q3 2020 · Sep 30, 2020 −$0.61
Eps Basic Q3 2020 · Sep 30, 2019 $0.03
Eps Basic Q3 2020 · Sep 30, 2019 −$0.01
Sga Expense Q3 2020 · Sep 30, 2020 $5.4M
Sga Expense Q3 2020 · Sep 30, 2020 $17.98M
Sga Expense Q3 2020 · Sep 30, 2019 $5.53M
Sga Expense Q3 2020 · Sep 30, 2019 $16.23M
Rd Expense Q3 2020 · Sep 30, 2020 $2.61M
Rd Expense Q3 2020 · Sep 30, 2020 $7.73M
Rd Expense Q3 2020 · Sep 30, 2019 $1.63M
Rd Expense Q3 2020 · Sep 30, 2019 $6.04M
Net Income Q3 2020 · Sep 30, 2020 −$149K
Net Income Q3 2020 · Sep 30, 2020 −$15.86M
Net Income Q3 2020 · Jun 30, 2020 −$9.69M
Net Income Q3 2020 · Mar 31, 2020 −$6.03M
Net Income Q3 2020 · Sep 30, 2019 $717K
Net Income Q3 2020 · Sep 30, 2019 −$189K
Net Income Q3 2020 · Jun 30, 2019 $590K
Net Income Q3 2020 · Mar 31, 2019 −$1.5M
Operating Income Q3 2020 · Sep 30, 2020 $275K
Operating Income Q3 2020 · Sep 30, 2020 −$16.14M
Operating Income Q3 2020 · Sep 30, 2019 $122K
Operating Income Q3 2020 · Sep 30, 2019 −$4.21M
Gross Profit Q3 2020 · Sep 30, 2020 $14.86M
Gross Profit Q3 2020 · Sep 30, 2020 $28.83M
Gross Profit Q3 2020 · Sep 30, 2019 $15.49M
Gross Profit Q3 2020 · Sep 30, 2019 $40.24M